Last €8.46 EUR
Change Today +0.01 / 0.12%
Volume 3.2K
SSI On Other Exchanges
Symbol
Exchange
EN Paris
Berlin
As of 7:53 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

supersonic imagine sa (SSI) Snapshot

Open
€8.45
Previous Close
€8.45
Day High
€8.47
Day Low
€8.30
52 Week High
05/29/14 - €11.58
52 Week Low
10/16/14 - €6.12
Market Cap
135.9M
Average Volume 10 Days
18.1K
EPS TTM
--
Shares Outstanding
16.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SUPERSONIC IMAGINE SA (SSI)

Related News

No related news articles were found.

supersonic imagine sa (SSI) Related Businessweek News

No Related Businessweek News Found

supersonic imagine sa (SSI) Details

SuperSonic Imagine SA operates as a medical imaging company. The company develops the Aixplorer, an ultrasound system used in various applications, such as general imaging, women’s healthcare, vascular, hepatology/gastroenterology, and research. The company sells its products through a direct sales force and a distribution network in approximately 50 countries worldwide. SuperSonic Imagine SA was founded in 2005 and is headquartered in Aix-en-Provence, France.

126 Employees
Last Reported Date: 03/27/14
Founded in 2005

supersonic imagine sa (SSI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

supersonic imagine sa (SSI) Key Developments

SuperSonic Imagine Announces Revenue Results for the Third Quarter and Nine Months Ended September 30, 2014

SuperSonic Imagine announced revenue results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported sales of EUR 4,429,000 against EUR 3,634,000 a year ago. For the nine months, the company reported total revenue of EUR 13,644,000 against EUR 10,537,000 a year ago.

SuperSonic Imagine Launches Aixplorer Musculoskeletal Application

SuperSonic Imagine announced the launch of a new musculoskeletal application on its ultrasound machine, the Aixplorer, which will facilitate musculoskeletal and sports medicine diagnoses. Aixplorer, the new reference in musculoskeletal imaging Already covering all general imaging applications, the company is now widening its scope to cover musculoskeletal and sports medicine. The new high-frequency "hockey stick" transducer (the SHL20-6) provides very high-resolution images of muscles, tendons, ligaments and joints. It complements the linear transducer range to provide unrivalled image quality for both very superficial and deep zones. The company’s patented ShearWave Elastography system allows practitioners to view and measure tissue stiffness of up to 800kPa in real-time. This is particularly useful for diagnosing and monitoring tendinopathies and examining muscular load with real-time visualization of the anatomic and functional image of the muscle in full use.

Supersonic Imagine Launches multicentric Clinical Trial

SuperSonic Imagine announced the launch of a multicentric clinical trial. The aim of the trial is to determine how ShearWave(TM) Elastography can contribute to the diagnosis of breast lesions in a population of Asian patients. The initiative is part of the company's clinical strategy and aims at validating the clinical benefits of its technology. A previous study in 2011 involving 1,800 patients demonstrated that ShearWave(TM) Elastography, combined with conventional ultrasound criteria, provided better diagnosis of mammary lesions by significantly improving the specificity of the examination. Since then, the elastography criterion has been incorporated into the BI-RADS(R) classification by the American College of Radiology, and other academic societies have published recommendations of practice that unanimously acknowledge the results of the initial trial. The trial currently underway in China will recruit approximately 2,000 patients. In addition to confirming the benefits of ShearWave(TM) Elastography on a broad population, the primary objective is to determine the clinical benefits of this technology on a specific group which differs from the Caucasian population, given that Asian women tend to have denser breast tissue. The direction of the trial promoted by SuperSonic Imagine, has been entrusted to Professor Chang (Shanghai) and Professor Li (Guangzhou). Professors Chang and Li will be responsible for controlling the data collected from the 20 locations, which include the finest hospitals in Shanghai, Guangzhou, Beijing, Harbin, Xi'an, Chengdu, and Taiyuan.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SSI:FP €8.46 EUR +0.01

SSI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SSI.
View Industry Companies
 

Industry Analysis

SSI

Industry Average

Valuation SSI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 5.5x
Price/Book 2.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SUPERSONIC IMAGINE SA, please visit www.supersonicimagine.fr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.